Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Other Accumulated Expenses (2022 - 2025)

Core Laboratories (CLB) has 4 years of Other Accumulated Expenses data on record, last reported at $3.9 million in Q3 2025.

  • For Q3 2025, Other Accumulated Expenses fell 33.53% year-over-year to $3.9 million; the TTM value through Sep 2025 reached $3.9 million, down 33.53%, while the annual FY2024 figure was $8.2 million, 37.35% up from the prior year.
  • Other Accumulated Expenses reached $3.9 million in Q3 2025 per CLB's latest filing, down from $9.1 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $9.3 million in Q1 2024 and bottomed at $3.9 million in Q3 2025.
  • Average Other Accumulated Expenses over 4 years is $6.6 million, with a median of $5.9 million recorded in 2023.
  • The widest YoY moves for Other Accumulated Expenses: up 84.04% in 2025, down 50.67% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $8.4 million in 2022, then dropped by 28.96% to $5.9 million in 2023, then soared by 37.35% to $8.2 million in 2024, then tumbled by 52.78% to $3.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $3.9 million in Q3 2025, $9.1 million in Q2 2025, and $4.6 million in Q1 2025.